Health & Drugs

Elan, Biogen change Tysabri label due to PML risk Saturday, 7 Nov 2009

DUBLIN, Nov 7 (Reuters) - Ireland's Elan and U.S. drugmaker Biogen Idec have amended the label of their multiple sclerosis drug Tysabri to reflect the increased risk of contracting a potentially deadly brain infection, Elan said in a statement on Saturday. Full Article

Bioton has new CEO, main investor eyes biotech Saturday, 7 Nov 2009

WARSAW, Nov 7 (Reuters) - The Head of Poland's insulin maker Bioton , Janusz Guy, has stepped down and will be replaced by Slawomir Ziegert, the company said in a statement late on Friday. Full Article

Glaxo for now Saudi's sole supplier of H1N1 vaccine Saturday, 7 Nov 2009

RIYADH, Nov 7 (Reuters) - British drugmaker GlaxoSmithKline is currently Saudi Arabia's sole supplier of a vaccine for the H1N1 flu virus, the health ministry spokesman said on Saturday. Full Article

More Health & Drugs News

Dr Reddy's files for marketing Lipitor generic Saturday, 7 Nov 2009

MUMBAI, Nov 7 (Reuters) - India's Dr Reddy's Laboratories has filed for marketing a generic version of Pfizer's cholesterol-lowering drug Lipitor in the U.S., the company said on Saturday. Full Article

UPDATE 1-Abbott faces new US sales probe, Depakote in focus Saturday, 7 Nov 2009

* Involves Medicare, Medicaid payments to third parties Full Article

UPDATE 4-Boston Sci to pay $296 mln to settle US probe Friday, 6 Nov 2009

* Reaches agreement with U.S. DOJ over Guidant advisories Full Article

UPDATE 2-India, EU to resolve generic drug dispute-minister Friday, 6 Nov 2009

* India says drug shipment consistent with WTO regulations Full Article

UPDATE 1-Labopharm posts wider Q3 loss as revenue falls 30 pct Friday, 6 Nov 2009

Nov 6 (Reuters) - Labopharm Inc posted a wider quarterly loss, as the Canadian drugmaker earned lower licensing revenue from its once-daily tramadol pain treatment and said it would cut about 35 jobs under plan to streamline operations. Full Article

UPDATE 1-Par Pharma Q3 profit beats estimates on strong revenue Friday, 6 Nov 2009

Nov 6 (Reuters) - Generic drugmaker Par Pharmaceutical Cos Inc reported a higher quarterly profit that significantly beat analysts' estimates, helped by new drug launches and limited competition against some of its key products. Full Article

India, EU to resolve generic drug dispute-trade min Friday, 6 Nov 2009

NEW DELHI, Nov 6 (Reuters) - India will resolve a dispute with the European Union over generic drugs in an amicable way, Trade Minister Anand Sharma said on Friday. Full Article